Why Swallowing a Peptide Usually Fails

The obstacle course

A peptide taken by mouth meets three barriers in sequence:

1. Stomach acid and pepsin start cutting the chains.
2. Pancreatic enzymes (trypsin, chymotrypsin) keep cutting in the small intestine.
3. The gut wall is a tight barrier. Large, charged, water-loving molecules barely cross it.

Very little of a swallowed peptide reaches the blood. Even the approved oral semaglutide tablet, built with an absorption enhancer, has an absolute bioavailability of only 0.4 to 1 percent.

Why injections dominate

Injection skips the whole route. That is why many peptide medicines are given under the skin, and why people ask whether a pill version can exist.

Tricks that have worked

• Absorption enhancers that help the peptide cross the lining for a short time, close to where the pill dissolves.
• Enteric coatings that survive acid and open further down.
• Cyclisation or D-residues that enzymes struggle to recognise.
• Tiny protective microenvironments around the tablet. The enhancer in oral semaglutide buffers the acid locally and so shields the peptide from enzymes in the stomach.

A caution for consumers

When a capsule label promises an intact peptide reaching the bloodstream, ask for human absorption data. Without it, the likeliest outcome is digestion into ordinary amino acids.